awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30317831-C2E91BDA-30EB-46BB-A082-322A802AEC8A
Q30317831-C2E91BDA-30EB-46BB-A082-322A802AEC8A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30317831-C2E91BDA-30EB-46BB-A082-322A802AEC8A
Reduced immunosuppressive properties of axitinib in comparison with other tyrosine kinase inhibitors.
P2860
Q30317831-C2E91BDA-30EB-46BB-A082-322A802AEC8A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30317831-C2E91BDA-30EB-46BB-A082-322A802AEC8A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ace6d896161a21ec96aa8b1b4830084456f03849
P2860
Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.